These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32829523)

  • 41. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
    Duquesnoy RJ; Askar M
    Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A structurally based approach to determine HLA compatibility at the humoral immune level.
    Duquesnoy RJ
    Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
    Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
    J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.
    Bosch A; Llorente S; Eguia J; Mrowiec A; Boix F; López-Hernández R; Campillo JA; Salgado G; Moya-Quiles MR; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2014 Apr; 75(4):338-41. PubMed ID: 24486575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenic HLA class I epitopes identified by humoral response to pregnancies.
    Maruya E; Sasaki N; El-Awar N; Akaza T; Kitawaki J; Saji H; Terasaki PI
    Clin Transpl; 2008; ():215-27. PubMed ID: 19708458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
    Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity.
    Duquesnoy RJ
    Front Immunol; 2011; 2():59. PubMed ID: 22566848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation.
    Lobashevsky A; Goggins W; Rosner K; Taber T
    Transpl Immunol; 2017 Aug; 43-44():42-48. PubMed ID: 28629951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications.
    Duquesnoy RJ
    Tissue Antigens; 2011 Jun; 77(6):525-34. PubMed ID: 21410655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays.
    Duquesnoy RJ; Marrari M; Jelenik L; Zeevi A; Claas FH; Mulder A
    Hum Immunol; 2013 Oct; 74(10):1271-9. PubMed ID: 23770250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Ioannou S; Iniotaki-Theodoraki A; Kostakis A
    Eur J Immunogenet; 2002 Oct; 29(5):401-7. PubMed ID: 12358849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First report on the antibody verification of MICA epitopes recorded in the HLA epitope registry.
    Duquesnoy RJ; Mostecki J; Marrari M; da Silva AS; da Mata Sousa LC; do Monte SJ
    Int J Immunogenet; 2014 Oct; 41(5):370-7. PubMed ID: 25053277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of the Nonself-Self Algorithm of HLA Epitope Immunogenicity in the Specificity Analysis of Monospecific Antibodies Induced during Pregnancy.
    Duquesnoy RJ; Marrari M; Mulder A
    Front Immunol; 2015; 6():180. PubMed ID: 26074914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns.
    Duquesnoy RJ; Mostecki J; Hariharan J; Balazs I
    Hum Immunol; 2008 Dec; 69(12):826-32. PubMed ID: 18957310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software.
    Tassone G; De Santis D; Vukovic I; Downing J; Martinez OP; D'Orsogna LJ
    HLA; 2020 Jul; 96(1):52-63. PubMed ID: 32281731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.